Finch Therapeutics Group (FNCH) News Today $11.95 -0.20 (-1.65%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Finch Therapeutics Group, Inc.: Finch Announces Delisting from Nasdaq and SEC DeregistrationOctober 23, 2024 | finanznachrichten.deFinch Therapeutics announces Nasdaq delisting, SEC deregistrationOctober 22, 2024 | markets.businessinsider.comFinch Therapeutics Group to Delist from NasdaqOctober 22, 2024 | markets.businessinsider.comFinch Announces Delisting from Nasdaq and SEC DeregistrationOctober 21, 2024 | globenewswire.comFinch Therapeutics Gr (OTC:FNCH) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comFinch wins US jury trial against Ferring over fecal-transplant patentsAugust 10, 2024 | reuters.comTrading was temporarily halted for "FNCH" at 09:04 AM with a stated reason of "LULD pause."April 17, 2024 | marketbeat.comFinch Therapeutics Group (NASDAQ: FNCH)April 14, 2024 | fool.comJeffery A. Smisek Sells 6,642 Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH) StockMarch 31, 2024 | insidertrades.comFNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q4 2023March 25, 2024 | investorplace.comFinch Therapeutics Group Inc (FNCH)March 7, 2024 | investing.comFinch Therapeutics Gr Stock (NASDAQ:FNCH), Short Interest ReportFebruary 22, 2024 | benzinga.comTrading was temporarily halted for "FNCH" at 03:12 PM with a stated reason of "LULD pause." Trading set to resume at 03:12 PM. December 1, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 09:12 AM with a stated reason of "LULD pause."December 1, 2023 | marketbeat.comFinch Therapeutics Group Inc FNCHNovember 5, 2023 | morningstar.comTrading was temporarily halted for "FNCH" at 09:10 AM with a stated reason of "LULD pause."October 18, 2023 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)August 21, 2023 | markets.businessinsider.comTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."June 12, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 03:06 PM with a stated reason of "LULD pause."June 12, 2023 | marketbeat.comTrading was temporarily halted for "FNCH" at 02:06 PM with a stated reason of "LULD pause."June 12, 2023 | marketbeat.comFinch Therapeutics Group, Inc.: Finch Announces Reverse Stock Split of Common StockJune 9, 2023 | finanznachrichten.deHC Wainwright & Co. Reiterates Finch Therapeutics Group (FNCH) Buy RecommendationMay 13, 2023 | msn.com8-K: Finch Therapeutics Group, Inc.May 12, 2023 | marketwatch.comFinch Therapeutics Group, Inc.: Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 10, 2023 | finanznachrichten.deFinch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 10, 2023 | finance.yahoo.comFinch Therapeutics Announces Executive Leadership TransitionsApril 25, 2023 | finance.yahoo.comFINCH THERAPEUTICS GROUP INCApril 22, 2023 | finanznachrichten.deFinch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License AgreementApril 18, 2023 | finance.yahoo.comFinch Therapeutics Group (FNCH) Gets a Buy from H.C. WainwrightApril 4, 2023 | markets.businessinsider.comFinch Therapeutics Group, Inc.: Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesApril 3, 2023 | finanznachrichten.deLooking Into Finch Therapeutics Group's Return On Capital EmployedMarch 25, 2023 | msn.comFinch Therapeutics Group Full Year 2022 Earnings: Misses ExpectationsMarch 25, 2023 | finance.yahoo.comFinch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesMarch 23, 2023 | finance.yahoo.comMicrobiome startup cuts 95% of remaining staff in 3rd layoff in 9 monthsJanuary 24, 2023 | finance.yahoo.comFinch Therapeutics Ending Phase 3 Study, Cutting Most of Workforce >FNCHJanuary 24, 2023 | marketwatch.comFinch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other AssetsJanuary 24, 2023 | finance.yahoo.comTrading was temporarily halted for "FNCH" at 07:01 AM with a stated reason of "News pending."January 24, 2023 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Kezar Life Sciences (KZR), RVL Pharmaceuticals (RVLP)November 11, 2022 | markets.businessinsider.comFinch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial ResultsNovember 11, 2022 | finance.yahoo.comFinch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx ConferenceNovember 9, 2022 | finance.yahoo.comFinch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile InfectionOctober 24, 2022 | finance.yahoo.comFNCH Finch Therapeutics Group, Inc.October 1, 2022 | seekingalpha.comAfter Takeda ends collaboration, microbiome startup Finch Therapeutics cuts 50 jobsSeptember 1, 2022 | finance.yahoo.comFinch Therapeutics To Reduce Workforce - Quick FactsSeptember 1, 2022 | markets.businessinsider.comFinch Therapeutics Provides Business UpdateSeptember 1, 2022 | finance.yahoo.comFinch Therapeutics Group, Inc. (NASDAQ:FNCH) Short Interest Down 19.6% in AugustFinch Therapeutics Group, Inc. (NASDAQ:FNCH - Get Rating) was the target of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 231,400 shares, a decrease of 19.6% from the July 31st total of 287,700 shares. Approximately 1.5% of the company's stock are short sold. Based on an average trading volume of 82,400 shares, the short-interest ratio is currently 2.8 days.August 29, 2022 | marketbeat.comFinch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial ResultsAugust 11, 2022 | finance.yahoo.comHere's Why We're Watching Finch Therapeutics Group's (NASDAQ:FNCH) Cash Burn SituationAugust 10, 2022 | finance.yahoo.comAs Finch Therapeutics Group, Inc.'s market cap (NASDAQ:FNCH) drops to US$103m, insiders might be questioning their decision to buy earlier this yearJuly 20, 2022 | nasdaq.comAs Finch Therapeutics Group, Inc. (NASDAQ:FNCH) drops to US$103m market cap, insiders might rethink their US$650k stock purchase earlier this yearJuly 20, 2022 | finance.yahoo.com Get Finch Therapeutics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FNCH and its competitors with MarketBeat's FREE daily newsletter. Email Address 2 sentences that change everything you THOUGHT you knew about trading (Ad)If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running. Click here. FNCH Media Mentions By Week FNCH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FNCH News Sentiment▼0.000.45▲Average Medical News Sentiment FNCH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FNCH Articles This Week▼00▲FNCH Articles Average Week Get Finch Therapeutics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for FNCH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALGS News RAPT News MIST News SLS News ALXO News CLSD News ANL News DBVT News PRLD News CTXR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FNCH) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
